{"id":"triamcinolone-plus-hyruan","safety":{"commonSideEffects":[{"rate":null,"effect":"Local injection site pain or swelling"},{"rate":null,"effect":"Transient increase in joint pain (post-injection flare)"},{"rate":null,"effect":"Infection at injection site"},{"rate":null,"effect":"Systemic corticosteroid effects (with repeated dosing)"}]},"_chembl":{"chemblId":"CHEMBL1200449","moleculeType":"Small molecule","molecularWeight":"478.51"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Triamcinolone is a corticosteroid that suppresses inflammatory cytokines and immune cell infiltration. Hyaluronic acid is a naturally occurring polysaccharide that acts as a lubricant and protective agent in joints and tissues. The combination leverages anti-inflammatory and protective mechanisms for joint or soft tissue disorders.","oneSentence":"Triamcinolone reduces inflammation via glucocorticoid receptor activation, while hyaluronic acid (hyruan) provides lubrication and tissue protection through its viscoelastic properties.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:39:05.188Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Osteoarthritis or joint inflammation (intra-articular injection)"},{"name":"Soft tissue inflammation and pain"}]},"trialDetails":[{"nctId":"NCT05861570","phase":"NA","title":"Is Combined Steroid and Sodium Hyaluronate Hydrodilatation More Effective Than Isolated Steroid Hydrodilatation in Treating Patients With Adhesive Capsulitis","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2023-05-18","conditions":"Adhesive Capsulitis","enrollment":84},{"nctId":"NCT05220527","phase":"PHASE4","title":"Effects of Knee Injections on Patients With Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Taipei Medical University","startDate":"2020-08-01","conditions":"Knee Osteoarthritis, Injection, Effect of Drug","enrollment":60}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["corticosteroids plus hyaluronic acid"],"phase":"marketed","status":"active","brandName":"Triamcinolone plus hyruan","genericName":"Triamcinolone plus hyruan","companyName":"Taipei Medical University","companyId":"taipei-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Triamcinolone is a glucocorticoid receptor agonist, classified as a small molecule. It has been studied in combination with sodium hyaluronate (Hyruan) for treating conditions such as adhesive capsulitis and knee osteoarthritis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}